Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Use of Trypsin Versus Dispase in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo

NCT01822379 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT01822379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01822379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Use of Trypsin Versus Dispase in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo
Lead sponsor
Henry Ford Health System
Phase
Phase 2/3
Overall status
Withdrawn
Start date
May 31, 2010
Completion date
July 31, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo